|
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
OTCPink
|
1.
|
Election of Board of Directors. The following persons were elected as directors of the Company for a one-year term expiring at the 2024 Annual Meeting of Stockholders with the following vote:
|
Name
|
Votes For
|
Votes Against
|
Votes Withheld
|
Broker
Non-Votes |
Renato V. Bosita, Jr., MD
|
63,087,944
|
61,351
|
2
|
1,372,464
|
Mark W. Brooks
|
63,132,848
|
16,447
|
2
|
1,372,464
|
Lawrence S. Yellin
|
63,091,848
|
57,447
|
2
|
1,372,464
|
Christopher C. Reeg
|
63,132,854
|
16,441
|
2
|
1,372,464
|
2.
|
Ratification of the Selection of M&K CPAS, PLLC (M&K). The selection of M&K to act as an independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023 was ratified by a vote of (i) 64,474,346 in favor, (ii) 47,224 against, and (iii) 191 abstaining.
|
|
|
Fuse Medical, Inc.
|
|
|
|
|
|
Date: June 26, 2023
|
|
By:
|
/s/ Christopher C. Reeg
|
|
|
|
Christopher C. Reeg,
|
|
|
|
Chief Executive Officer and Director
|
Document And Entity Information |
Jun. 23, 2023 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | FUSE MEDICAL, INC. |
Document, Type | 8-K |
Document, Period End Date | Jun. 23, 2023 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 000-10093 |
Entity, Tax Identification Number | 59-1224913 |
Entity, Address, Address Line One | 1565 North Central Expressway |
Entity, Address, Address Line Two | Suite 220 |
Entity, Address, City or Town | Richardson |
Entity, Address, State or Province | TX |
Entity, Address, Postal Zip Code | 75080 |
City Area Code | 469 |
Local Phone Number | 862-3030 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | FZMD |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0000319016 |
RHY_U=3_ 102P,$% @ ,&_:5I>*NQS M $P( L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/ M: (7->=I3W;+T]!;X"O M.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_ M'36TGHX-R#8._AE8P=S8\?=_<#4$L#!!0 M ( #!OVE8D'INBK0 /@! : >&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&R MGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0 MDBBZ0=@S9)[NF:*/Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2 MXLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ M P04 " P;]I699!YDAD! #/ P $P %M#;VYT96YT7U1Y<&5S72YX M;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85- MK'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+ MY8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-FI6.5Z*U .EK >MKBRAE# MVQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/) MW55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_ ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0 ( #!OVE8'04UB@0 +$ 0 M " 0 !D;V-0 &UL4$L! A0#% @ ,&_: M5E0ZEFGO *P( !$ ( !KP &1O8U!R;W!S+V-O &UL4$L! A0#% @ ,&_:5IE &PO=V]R:W-H965T &UL4$L! A0#% @ ,&_:5I^@&_"Q @ X@P T ( ! MB0P 'AL+W-T>6QE &PO=V]R:V)O;VLN>&UL M4$L! A0#% @ ,&_:5B0>FZ*M ^ $ !H ( !NQ$ M 'AL+U]R96QS+W=O 9(9 0 SP, !, ( !H!( %M#;VYT96YT7U1Y<&5S72YX 8;6Q02P4& D "0 ^ @ ZA, end